USPTO serial 79452174
OQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2026
- Examiner
- PETTICAN, NATHANIEL VINCIENT
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; pharmaceutical preparations for use as a preparatory regimen in connection with bone marrow transplants; pharmaceutical preparations for the treatment and prevention of metabolic diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for inhibiting blood platelet aggregation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Similar marks named OQ
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2026 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 18, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |